Opening soon. Stay in the loop

goodmorrowJoin the opening list

NAD+, explained.

Nicotinamide adenine dinucleotide. Research, safety questions, and treatment context.

Updated Clinical review pending · Educational draft

The form

More than one catalog form

The routine

The route changes the experience.

The evidence

Small metabolism study · wellness benefits uncertain

Forms listed in a June 2025 catalog. Current availability and individual instructions need confirmation.

Legal status
Compoundable now

Not a peptide. Compoundable today with a prescription.

At Goodmorrow
Offered when we open

What it is

NAD+ is a coenzyme every cell uses to turn food into energy. Levels fall with age, which is the reasoning behind topping it up.

What the evidence shows

Raising NAD+ levels is easy. Showing that it makes people feel or function better is harder. Human trials of NAD+ boosters have mostly shown small or no changes in how people perform, and IV infusions have little controlled data.

How Goodmorrow handles it

We prefer short injections under the skin to long IV drips: the same idea in a fraction of the time. If you don't notice a difference in a month, stop.

Stacks that include it

Questions people ask

Is NAD+ worth it?

For some people it's a noticeable lift; for many it isn't. It's low risk and easy to test for a month. We'll tell you if we think you're wasting your money.

Sources

  1. Secondary sourceThe US Peptide Status Index Peptide America

Good days ahead.

Join the opening list for appointment updates.

Join the opening list